Clinically significant findings in a decade ‐long retrospective study of prenatal chromosomal microarray testing

ConclusionOur CMA study supports the clinical utility of prenatal CMA for clinical management and identifying genetic etiology in POC arrays. In addition, it provides insight to the spectrum of prenatal and POC CMA results as detected in an academic hospital clinical laboratory setting that serves as a reference laboratory.

Source: Molecular Genetics & Genomic Medicine - January 24, 2024 Category: Genetics & Stem Cells Authors: Joie O. Olayiwola, Mohammad Marhabaie, Daniel Koboldt, Theodora Matthews, Amy Siemon, Danielle Mouhlas, Taylor Porter, George Kyle, Cortlandt Myers, Hui Mei, Ying ‐Chen Claire Hou, Melanie Babcock, Jesse Hunter, Kathleen M. Schieffer, Yass Tags: ORIGINAL ARTICLE Source Type: research